Research & Development



  淡黃色的茶水清澈透明,除過濃郁的茶香之外,即便仔細嗅也沒有其余的怪味道。   不用雲瑯審判,他們自己搭建好了架子,將十九個他們認為罪大惡極的羌人用繩子給吊死了。全球彩票1.0   閆長春點點頭,揮揮手,右手邊的兩個武士就奮力向山壁攀援,很快就消失在林莽之中。全球彩票官方下载   七個最忠勇,最傷心的匈奴猛士也在同一時間覺得心口痛了一下,低頭就看見了屬于漢軍的三稜破甲錐!   閆長春點點頭,揮揮手,右手邊的兩個武士就奮力向山壁攀援,很快就消失在林莽之中。全球彩票所有版本   何愁有拍拍雲瑯的肩膀怒道︰“將軍在分布將令,你因何三心二意?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo